Mode
Text Size
Log in / Sign up
N/A N=29 Randomized Basic Science

Olfactory Contributions to Sleep-dependent Food Craving

Sleep Deprivation

Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Functional Magnetic Resonance Imaging (fMRI)-Based Decoding Accuracy of Food vs Non-food Odors in Piriform Cortex — 54.38; 49.65 Percentage correctly classified — p=0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Sleep-Deprived (Behavioral); Non-Sleep Deprived (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Northwestern University
Primary completion
Aug 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Functional Magnetic Resonance Imaging (fMRI)-Based Decoding Accuracy of Food vs Non-food Odors in Piriform Cortex
54.38; 49.65 0.001 sig
SECONDARY
Energy-density of Consumed Food
3.88; 3.68 0.021 sig
SECONDARY
Ghrelin
584.33; 573.47 0.63
SECONDARY
Leptin
10.19; 9.68 0.08
SECONDARY
Total Calories of Consumed Food
932.86; 946.49 0.28
SECONDARY
Insulin
42.53; 48.56 0.50
SECONDARY
Cortisol
6.08; 7.50 0.58

Summary

This within-subject experiment uses one night of acute sleep restriction (4h) vs normal sleep (8h) to study state-dependent changes in olfactory processing. Odor-evoked blood oxygen level dependent (BOLD) responses will be measured in olfactory brain regions using functional magnetic resonance imaging (fMRI). Food intake will be measured at a buffet.

Eligibility Criteria

Inclusion Criteria

  • age between 18 and 40 years old
  • regular sleep schedule (average sleep duration of ≥7 h/night, habitual mid-sleep time 3-5 am [deviation ≤2 h in daily mid-sleep time], time in bed ≤9 h)
  • right-handed
  • fluent English speakers

Exclusion Criteria

  • history of significant cerebrovascular disease including (but not limited to) epilepsy, stroke, multiple sclerosis, meningitis
  • body mass index (BMI) below 18.5 (underweight) or above 24.9 (overweight or obese)
  • history of sleep disorder
  • job with night shifts
  • history of major head trauma with sustained loss of consciousness
  • history of neurosurgery, ear-nose-throat (ENT) surgery, or cardiac surgery
  • history of cardiac pacemaker or neurostimulator implantation
  • history of significant medical illness including cardiovascular disease, diabetes, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, etc.
  • history of major psychiatric disorder including major affective disorder, obsessive-compulsive disorder, schizophrenia
  • claustrophobia
  • history of significant food or non-food allergy, including latex, detergents, soaps
  • presence of known smell, taste or ENT disorder
  • history of sinusitis or allergic rhinitis
  • history of alcoholism or consistent drug use
  • current smoking
  • current use of medications that affect alertness (e.g. barbiturates, benzodiazepines, cannabinoids, chloral hydrate, haloperidol, lithium, carbamazepine, phenytoin, etc.)
  • current pregnancy (or possible pregnancy)
  • history of metal working, or injury with shrapnel or metal slivers
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04179838). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search